1. Home
  2. VRA vs LCTX Comparison

VRA vs LCTX Comparison

Compare VRA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.95

Market Cap

110.9M

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.30

Market Cap

301.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
LCTX
Founded
1982
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
301.7M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
VRA
LCTX
Price
$3.95
$1.30
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
N/A
$6.25
AVG Volume (30 Days)
468.0K
2.1M
Earning Date
06-10-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
20.47
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
$14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
53.24
52 Week Low
$1.39
$0.93
52 Week High
$4.39
$2.09

Technical Indicators

Market Signals
Indicator
VRA
LCTX
Relative Strength Index (RSI) 58.45 51.70
Support Level $2.17 N/A
Resistance Level $4.37 $1.32
Average True Range (ATR) 0.31 0.06
MACD 0.04 0.02
Stochastic Oscillator 65.25 55.65

Price Performance

Historical Comparison
VRA
LCTX

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: